SEW.DE Semperit (XETRA) closes €12.68 on 10 Mar 2026: Oversold bounce may spark rally

The SEW.DE stock closed at €12.68 on XETRA on 10 Mar 2026, up 1.44% on light volume as the name shows a classic oversold bounce setup. Price sits below the 50-day (€13.12) and 200-day (€13.32) averages, while year low is €11.12, leaving room for a measured recovery. Traders should note thin intraday volume (488 shares) and a negative EPS of -0.44, which keeps risk elevated despite technical support near recent lows. We outline near-term targets, valuation context, and Meyka AI model forecasts below.

Market snapshot and recent price action

Semperit AG Holding (SEW.DE) closed at €12.68 on XETRA in Germany, with a one-day move of +€0.18 (1.44%). Volume was 488 versus an average of 165, giving a relative volume of 2.96 that implies short-term attention but low absolute liquidity. The stock trades off the year high of €15.18 and above the year low of €11.12, leaving a 14.03% cushion from the low and a -16.45% gap to the high.

SEW.DE stock technical outlook

Price is below both the 50-day (€13.12) and 200-day (€13.32) moving averages, a setup consistent with an oversold bounce trade. The Keltner channel center sits at €12.68, matching today’s close and indicating compression that can lead to a short-term mean-reversion move. Watch a break above €13.50 for confirmation of a swing toward the next resistance at €15.18.

Valuation and key financial metrics

Semperit shows a market cap of €260.87M, EPS of -0.44 and a negative P/E of -28.82, reflecting recent losses. Key ratios include Price/Book 0.66, Price/Sales 0.40, and Free Cash Flow Yield 15.48%, underlining cheapness relative to fundamentals. The company pays €0.50 per share in dividends, giving a yield of 3.97%, but payout sustainability is constrained by negative earnings.

Meyka AI technical grade and model forecasts

Meyka AI rates SEW.DE with a score out of 100: 68.32/100 — Grade B (HOLD). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a 12-month price of €12.03, implying an approximate -5.10% downside from today’s €12.68. Forecasts are model-based projections and not guarantees.

Catalysts, risks and sector context

Catalysts for an oversold bounce include stronger-than-expected order flow in the Semperflex or Sempermed divisions and any operational updates ahead of the next earnings date. Risks include continued negative EPS, thin trading liquidity, and sector cyclicality in Industrials. The Industrials sector shows YTD strength of 3.94%, which can help a cyclical recovery if macro momentum holds.

Price targets and trade plan

For an oversold-bounce strategy, a short-term target of €13.50 is a practical take-profit level; a conservative recovery target is €15.18 (year high). A stop under €11.90 limits downside if the bounce fails. Position size should reflect low liquidity. Analysts’ consensus is limited; use model targets alongside risk controls.

Final Thoughts

SEW.DE stock shows a textbook oversold bounce opportunity after closing €12.68 on XETRA on 10 Mar 2026. Technicals favour a short-term mean reversion with a first objective at €13.50 and a stretch target at the year high of €15.18, but fundamentals are mixed: negative EPS (-0.44), negative P/E, yet attractive cash metrics like Free Cash Flow Yield 15.48% and Price/Book 0.66. Meyka AI’s forecast model projects €12.03 over 12 months, implying -5.10% versus current price; traders should treat that as a model-based baseline, not a guarantee. Given thin volume (488) and sector cyclicality, implement tight stops and size positions conservatively. For a balanced approach, consider partial profit-taking near €13.50 and reassess on a confirmed close above the 50-day average.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.